1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          Antacid Market – By Dosage Form

1.3.2          Antacid Market – By Drug Class

1.3.3          Antacid Market – By Distribution Channel

1.3.4          Asia Pacific Antacid Market – By Country

2.           Asia Pacific Antacid Market – Key Takeaways

3.           Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           Asia Pacific Antacid Market – Market Landscape

4.1          Overview

4.2          PEST Analysis

4.2.1          Antacid Market- Asia Pacific PEST Analysis

4.3          Expert Opinion

5.           Asia Pacific Antacid Market - Key Market Dynamics

5.1          Market Drivers

5.1.1          Increasing Innovative Product Launches by Market Players

5.1.2          Higher Incidence of the Obese Population

5.2          Market Restraints

5.2.1          Stringent Regulatory Norms and Several Challenges Associated with Gastrointestinal Diseases

5.3          Market Opportunities

5.3.1          Increasing Demand for OTC (Over the Counter) Antacid Medications

5.4          Future Trends

5.4.1          Rising Development of the Pharmaceutical Industry

5.5          Impact Analysis

6.           Antacid Market – Asia Pacific Analysis

6.1          Asia Pacific Antacid Market Revenue Forecasts and Analysis

7.           Asia Pacific Antacid Market Analysis and Forecasts to 2027 – By Dosage Form

7.1          Overview

7.2          Antacid Market Revenue Share, by Dosage Form (2019 and 2027)

7.3          Tablet

7.3.1          Overview

7.3.2          Tablet: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

7.4          Liquid

7.4.1          Overview

7.4.2          Liquid: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

7.5          Others

7.5.1          Overview

7.5.2          Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.           Asia Pacific Antacid Market Analysis and Forecasts to 2027– By Drug Class

8.1          Overview

8.2          Antacid Market Revenue Share, by Drug Class (2019 and 2027)

8.3          Proton Pump Inhibitors

8.3.1          Overview

8.3.2          Proton Pump Inhibitors: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.4          H Antagonist

8.4.1          Overview

8.4.2          H Antagonist: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.5          Acid Neutralizers

8.5.1          Overview

8.5.2          Acid Neutralizers: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.5.3          Magaldrate

8.5.3.1             Overview

8.5.3.2             Magaldrate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.5.4          Sucralfate

8.5.4.1             Overview

8.5.4.2             Sucralfate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.5.5          Others

8.5.5.1             Overview

8.5.5.2             Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

9.           Asia Pacific Antacid Market Analysis and Forecasts to 2027– By Distribution Channel

9.1          Overview

9.2          Antacid Market Share, by Distribution Channel, 2019 and 2027, (%)

9.3          Hospital Pharmacy

9.3.1          Overview

9.3.2          Hospital Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

9.4          Retail Pharmacy

9.4.1          Overview

9.4.2          Retail Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

9.5          Online Pharmacy

9.5.1          Overview

9.5.2          Online Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

10.        Antacid Market Revenue and Forecasts to 2027 – Geographical Analysis

10.1        Asia-Pacific: Antacid Market

10.1.1        Overview

10.1.2        Asia-Pacific: Antacid Market, by Country, 2019 & 2027 (%)

10.1.3        China: Antacid Market, – Revenue and Forecast to 2027 (USD Million)

10.1.3.1          China: Antacid Market, – Revenue and Forecast to 2027 (USD Million)

10.1.3.2          China: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

10.1.3.3          China: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.1.3.3.1           China: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

10.1.3.4          China: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.4        Japan: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.1          Japan: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.2          Japan: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

10.1.4.3          Japan: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.1.4.3.1           Japan: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

10.1.4.4          Japan: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.5        India: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.1          India: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.2          India: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

10.1.5.3          India: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.1.5.4          India: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

10.1.5.5          India: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.6        South Korea: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.1          South Korea: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.2          South Korea: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

10.1.6.3          South Korea: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.1.6.3.1           South Korea: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

10.1.6.4          South Korea: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.7        Australia: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1          Australia: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2          Australia: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

10.1.7.3          Australia: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.1.7.3.1           Australia: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

10.1.7.4          Australia: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.8        Rest of Asia Pacific: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1          Rest of Asia Pacific: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2          Rest of Asia Pacific: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

10.1.8.3          Rest of Asia Pacific: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.1.8.3.1           Rest of Asia Pacific: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

10.1.8.4          Rest of Asia Pacific: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.        Impact Of COVID-19 Pandemic on Asia Pacific Antacid Market

11.1        Asia Pacific: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1        Overview

12.2        Organic Developments

12.2.1        Overview

12.3        Inorganic Developments

12.3.1        Overview

13.        COMPANY PROFILES

13.1        Bayer AG

13.1.1        Key Facts

13.1.2        Business Description

13.1.3        Products and Services

13.1.4        Financial Overview

13.1.5        SWOT Analysis

13.1.6        Key Developments

13.2        GlaxoSmithKline plc.

13.2.1        Key Facts

13.2.2        Business Description

13.2.3        Products and Services

13.2.4        Financial Overview

13.2.5        SWOT Analysis

13.2.6        Key Developments

13.3        Takeda Pharmaceutical Company Limited

13.3.1        Key Facts

13.3.2        Business Description

13.3.3        Products and Services

13.3.4        Financial Overview

13.3.5        SWOT Analysis

13.3.6        Key Developments

13.4        Sun Pharmaceutical Industries Ltd

13.4.1        Key Facts

13.4.2        Business Description

13.4.3        Products and Services

13.4.4        Financial Overview

13.4.5        SWOT Analysis

13.4.6        Key Developments

13.5        Sanofi

13.5.1        Key Facts

13.5.2        Business Description

13.5.3        Products and Services

13.5.4        Financial Overview

13.5.5        SWOT Analysis

13.5.6        Key Developments

13.6        Boehringer Ingelheim International GmbH

13.6.1        Key Facts

13.6.2        Business Description

13.6.3        Products and Services

13.6.4        Financial Overview

13.6.5        SWOT Analysis

13.6.6        Key Developments

13.7        Dr. Reddy's Laboratories

13.7.1        Key Facts

13.7.2        Business Description

13.7.3        Products and Services

13.7.4        Financial Overview

13.7.5        SWOT Analysis

13.7.6        Key Developments

13.8        Pfizer Inc.

13.8.1        Key Facts

13.8.2        Business Description

13.8.3        roducts and Services

13.8.4        Financial Overview

13.8.5        SWOT Analysis

13.8.6        Key Developments

13.9        Reckitt Benckiser Group Plc

13.9.1        Key Facts

13.9.2        Business Description

13.9.3        Products and Services

13.9.4        Financial Overview

13.9.5        SWOT Analysis

13.9.6        Key Developments

13.10     Procter & Gamble

13.10.1      Key Facts

13.10.2      Business Description

13.10.3      Products and Services

13.10.4      Financial Overview

13.10.5      SWOT Analysis

13.10.6      Key Developments

14.        Appendix

14.1        About the Insight Partners

14.2        Glossary of Terms

LIST OF TABLES

Table 1.              China: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 2.              China: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 3.              China: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

Table 4.              China: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 5.              Japan: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 6.              Japan: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 7.              Japan: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

Table 8.              Japan: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 9.              India: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 10.            India: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 11.            India: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

Table 12.            India: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13.            South Korea: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 14.            South Korea: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 15.            South Korea: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

Table 16.            South Korea: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 17.            Australia: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 18.            Australia: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 19.            Australia: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

Table 20.            Australia: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 21.            Rest of Asia Pacific: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 22.            Rest of Asia Pacific: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 23.            Rest of Asia Pacific: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

Table 24.            Rest of Asia Pacific: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 25.            Organic Developments Done By Companies

Table 26.            Inorganic Developments Done By Companies

Table 27.            Glossary of Terms, Antacid Market

LIST OF FIGURES

Figure 1.            Antacid Market Segmentation

Figure 2.            Asia Pacific Antacid Market Overview

Figure 3.            Tablet Segment Held Largest Share of Dosage Form in Antacid Market

Figure 4.            Proton Pump Inhibitors Segment Held Largest Share of Drug Class in Antacid Market

Figure 5.            Japan is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.            Antacid Market - Asia Pacific PEST Analysis

Figure 7.            Antacid Market Impact Analysis of Driver and Restraints

Figure 8.            Asia Pacific Antacid Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.            Antacid Market Revenue Share, by Dosage Form (2019 and 2027)

Figure 10.          Tablet: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.          Liquid: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.          Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.          Antacid Market Revenue Share, by Drug Class (2019 and 2027)

Figure 14.          Proton Pump Inhibitors: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.          H Antagonist: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.          Acid Neutralizers: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.          Magaldrate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.          Sucralfate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.          Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.          Antacid Market Share, by Distribution Channel, 2019 and 2027 (%)

Figure 21.          Hospital Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.          Retail Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.          Online Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.          Asia-Pacific: Antacid Market, by Key Country – Revenue (2019) (USD Million)

Figure 25.          Asia-Pacific: Antacid Market, by Country, 2019 & 2027 (%)

Figure 26.          China: Antacid Market, – Revenue and Forecast to 2027 (USD Million)

Figure 27.          Japan Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.          India: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.          South Korea: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.          Australia: Antacid – Revenue and Forecast to 2027 (USD Million)

Figure 31.          Rest of Asia Pacific: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 32.          Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 33.          Growth Strategies Done by the Companies in the Market, (%)